In the News

Connect with us

Stay Informed.
Get the latest news and updates on MSK’s cancer care and research breakthroughs sent straight to your inbox with our e-newsletters.
Newsletter Sign Up
1852 News Items found
Pictured: PET Scan
In the Lab
New Imaging Agent Could Improve Prostate Cancer Diagnosis and Treatment

Researchers at Memorial Sloan Kettering are developing a new strategy for PET imaging of tumors that could result in new tools to detect and monitor prostate cancer.
Equipped for Discovery

Various facilities provide the services and technology that support Memorial Sloan Kettering’s cancer genomics studies.
Hundreds of high school students and teachers from the New York City area attend the annual seminar.
Event
Webcast of 2012 Major Trends in Modern Cancer Research

For the first time, our annual seminar for high school students and teachers from the New York City area will be available to watch live from around the nation and the world.
Pictured: Ping Chi
Q&A
At Work: Physician-Scientist Ping Chi

Dr. Chi, a physician-scientist and member of the Human Oncology and Pathogenesis Program, studies genetic and epigenetic changes that cause cancer.
Pictured: Scott Armstrong
Scott Armstrong and Kitai Kim Named to Endowed Chairs

Pediatric oncologist Scott A. Armstrong has been named the incumbent of the Grayer Family Chair, and stem cell biologist Kitai Kim has been named to a Geoffrey Beene Junior Faculty Chair.
Pictured: Zuckerman Research Center
Announcement
Pioneering Cancer Research Complex Nears Completion

Memorial Sloan Kettering’s new research complex contains more than 100 laboratories, nearly doubling the space we dedicate to research to better understand and treat cancer.
Pictured: Structure of Synthesized Erythropoietin
In the Lab
Memorial Sloan Kettering Investigators Synthesize Vital Biological Molecule Erythropoietin for the First Time

Researchers have produced a fully synthetic, functional version of erythropoietin, the hormone that controls production of red blood cells.
Pictured: Alexander Rudensky
Announcement
Alexander Rudensky Appointed Immunology Program Chair

Dr. Rudensky studies the development of white blood cells called T lymphocytes, which participate in the immune system response to infection. He joined the Sloan Kettering Institute in 2009.
Pictured: Tunneling Nanotubes
Snapshot
Tunneling Nanotubes Connect Cancer Cells

Memorial Sloan Kettering researchers have discovered a way that cancer cells may be able to exchange information by establishing long bridges between cells called tunneling nanotubes.
Pictured: Ross Levine
In the Lab
Researchers Discover Why Some Leukemia Drugs Are Not Sufficiently Effective

Memorial Sloan Kettering researchers have found why certain drugs are not sufficiently effective in treating leukemias called myeloproliferative neoplasms.